In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Medtronic's current price sits 22.9% below its high-confidence fair value estimate of $98.73, indicating potential upside. However, poor financial health scores and high Monte Carlo downside risk of 58.3% signal elevated volatility and leverage-related risk. Valuation methods diverge, reflecting mixed confidence in growth and profitability prospects.